1Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016[J]. CA Cancer J Clin, 2016, 66(1):7-30. DOI: 10.3322/caac.21332.
2Hampel H, Frankel W, Panescu J, et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients[J]. Cancer Res, 2006, 66(15): 7810-7817. DOI:10.1158/0008-5472.CAN-06-1114.
3Hampel H, Panescu J, Lockman J, et al. Comment on: Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients[J].Cancer Res, 2007, 67(19):9603. DOI:10.1158/0008-5472. CAN-07-2308.
4Warthin AS. Classics in oneology. Hereditary with reference to carcinoma as shown by the study of the eases examined in the pathological laboratory of tl~e University of Michigan, 1895-1913[J]. CA Cancer Y Chn; 1~85, 35(6):348-359.
5Lynch HT, Shaw MW, Magnuson. EW, et al. Hereditary factors in cancer. Study of t~o, |a~ge midwestern kindreds[J]. Arch Intern Med, 1966, 117(2):206-212.
6van Lier MG, Wagner A, van Leerdam ME, et al. A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory[J], J Cell Mol Med, 2010, 14(1-2): 181-197. DOI: 10.1111/j. 1582-4934.2009.00977.x.
7Vasen HF, Blanco I, Aktan-Collan K, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations, by a group of European experts [J]. Gut, 2013, 62(6):812-823. DOI: 10.1136/ gutjnl-2012-304356.
9Wang Y, Wang Y, Li J, et al. Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium[J]. J Hematol Oncol, 2013,6:22. DOI: 10.1186/ 1756-8722-6-22.
10Guarinos C, JuOrez M, Egoavil C,et al. Prevalence and characteristics of MUTYH-assoeiated polyposis in patients with multiple adenomatous and serrated polyps[J]. Clin Cancer Res, 2014, 20(5):1158-1168. DOI: 10.1158/1078- 0432.
2Lu KH, Broaddus RR. Gynecological tumors in hereditary nonpolyposis colorectal cancer: We know they are common-now what? Gynecol Oncol, 2001, 82:221-222.
3Broaddus RR, Lynch HT, Chen LM, et al. Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma. Cancer, 2006, 106:87-94.
4Ollikainen M, Abdel-Rahman WM, Moisio AL, et al. Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome.? J Clin Oncol, 2005, 23:4609-4616.
5Lu KH, Dinh M, Kohlmann W, et al. Gynecologic cancer as a " sentinel cancer " for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol, 2005, 105:569-574.
6Boks DE, TrujiUo AP, Voogd AC, et al. Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer. Int J Cancer, 2002, 102 : 198-200.
8Vasen HF, Watson P, Mecklin JP, et aL New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch Syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology, 1999, 116:1453-1456.
9Quehenberger F, Vasen HF, van Houwelingen HC. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet, 2005, 42:491-496.
